Ariogen Pharmed

Ariogen Pharmed is a leading Iranian biopharmaceutical company specializing in the development and manufacture of complex therapeutic proteins and monoclonal antibodies. Established in 2010 and part of the CinnaGen Pharmaceutical Group, the company operates one of the largest bioreactor facilities in the Middle East and North Africa (MENA) region. Its product portfolio includes biosimilars for oncology, autoimmune disorders, and hematology, such as trastuzumab, bevacizumab, and recombinant Factor VIIa. Ariogen provides end-to-end services from cell line development to large-scale GMP manufacturing, positioning itself as a key player in the regional biotech landscape. The company's facilities are designed to meet international quality standards, enabling the export of its biological products to various global markets. Ariogen's commitment to innovation and affordability has made it a critical provider of life-saving medications in its target regions.